Slavery exists in Australia in 2019, and the laws to prevent it are being systematically eroded.
Australia's supermarket duopoly sits at the head of a production chain that holds labourers in slave-like conditions, putting them at risk of serious injury or death.
While politicians and the media focus on people arriving by boat, asylum seekers are entering the country by plane in massive numbers — and the system can't keep up.
If Novo Nordisk is to fulfil the potential of its anti-obesity drug Saxenda, it needs more doctors to have a new understanding of how obesity really works. And to prescribe. Again and again.
The race to find a pharmacological way to combat obesity is on — and in addition to financial pressures, it has proven devilishly difficult to make an obesity drug that is effective, safe and works at scale, across a population.
Getting doctors and medical bodies to classify obesity as a 'disease' would be a huge win for pharmaceutical companies. Here's how they're trying to do just that.